These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The kinetic assembly of the intrinsic bovine factor X activation system. Beals JM; Chibber BA; Castellino FJ Arch Biochem Biophys; 1989 Feb; 268(2):485-501. PubMed ID: 2492418 [TBL] [Abstract][Full Text] [Related]
26. Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid. Morita T; Kisiel W Biochem Biophys Res Commun; 1985 Jul; 130(2):841-7. PubMed ID: 3875344 [TBL] [Abstract][Full Text] [Related]
27. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa. Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540 [TBL] [Abstract][Full Text] [Related]
28. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin. Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737 [TBL] [Abstract][Full Text] [Related]
29. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets. Yang X; Chang YJ; Lin SW; Walsh PN J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360 [TBL] [Abstract][Full Text] [Related]
30. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding. Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297 [TBL] [Abstract][Full Text] [Related]
31. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates. McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain. McCord DM; Monroe DM; Smith KJ; Roberts HR J Biol Chem; 1990 Jun; 265(18):10250-4. PubMed ID: 2355000 [TBL] [Abstract][Full Text] [Related]
33. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa. Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006 [TBL] [Abstract][Full Text] [Related]
35. Activation of normal and abnormal human factor IX with trypsin. Monroe DM; Noyes CM; Straight DL; Roberts HR; Griffith MJ Arch Biochem Biophys; 1985 May; 238(2):490-6. PubMed ID: 3873217 [TBL] [Abstract][Full Text] [Related]
36. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding. Ryan J; Wolitzky B; Heimer E; Lambrose T; Felix A; Tam JP; Huang LH; Nawroth P; Wilner G; Kisiel W J Biol Chem; 1989 Dec; 264(34):20283-7. PubMed ID: 2555350 [TBL] [Abstract][Full Text] [Related]
37. The role of phospholipid and factor VIIIa in the activation of bovine factor X. van Dieijen G; Tans G; Rosing J; Hemker HC J Biol Chem; 1981 Apr; 256(7):3433-42. PubMed ID: 6782101 [TBL] [Abstract][Full Text] [Related]
38. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function. Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991 [TBL] [Abstract][Full Text] [Related]
39. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme. Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466 [TBL] [Abstract][Full Text] [Related]
40. Characterization of a factor IX variant with a glycine207 to glutamic acid mutation. Lin SW; Lin CN; Hamaguchi N; Smith KJ; Shen MC Blood; 1994 Sep; 84(6):1866-73. PubMed ID: 7915915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]